• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY (BD) PAXGENE® BLOOD DNA TUBE; BLOOD SPECIMEN COLLECTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY (BD) PAXGENE® BLOOD DNA TUBE; BLOOD SPECIMEN COLLECTION DEVICE Back to Search Results
Catalog Number 762165
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Device Ingredient or Reagent Problem (2910)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/04/2022
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported when using the paxgene® blood dna tube, the device experienced erroneous results.This event occurred once.The following information was provided by the initial reporter.The customer stated: genomic contamination or dnase treatment has not worked properly."the blood is being collected at a hospital which collaborate with us, following your instructions (the tube is at room temperature when collected, it is the last tube to be extracted, the tube is inverted 10 times and leaved it at least 2 hours vertically).Then the tubes are sent to us and arrived the next day, we store them at -20ºc vertically and the next day we transfer them to -80ºc.We suspect there is genomic contamination or dnase has not worked properly".
 
Manufacturer Narrative
The following fields have been updated with corrected information: b.5.Describe event or problem: it was reported when using the paxgene® blood dna tube, the additive was abnormal.This event occurred once.The following information was provided by the initial reporter.The customer stated: genomic contamination or dnase treatment has not worked properly."the blood is being collected at a hospital which collaborate with us, following your instructions (the tube is at room temperature when collected, it is the last tube to be extracted, the tube is inverted 10 times and leaved it at least 2 hours vertically).Then the tubes are sent to us and arrived the next day, we store them at -20ºc vertically and the next day we transfer them to -80ºc.We suspect there is genomic contamination or dnase has not worked properly." h.6 idmrf annex a code: a0302.H.6.Investigation summary: bd had not received samples or photos for evaluation.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.No clinical testing can be performed for this defect.After review by our molecular specialist, it appears that the issue is related to the chemagic kit.The paxgene blood rna tube was designed specifically to work with preanalytix kits and we would not be able to troubleshoot issues with the chemagic kit.No further testing can be done as the product expired april 30, 2021.This complaint is unable to be confirmed for a sample quality issue.Bd was not able to identify a root cause for the indicated failure mode.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.
 
Event Description
It was reported when using the paxgene® blood dna tube, the additive was abnormal.This event occurred once.The following information was provided by the initial reporter.The customer stated: genomic contamination or dnase treatment has not worked properly."the blood is being collected at a hospital which collaborate with us, following your instructions (the tube is at room temperature when collected, it is the last tube to be extracted, the tube is inverted 10 times and leaved it at least 2 hours vertically).Then the tubes are sent to us and arrived the next day, we store them at -20ºc vertically and the next day we transfer them to -80ºc.We suspect there is genomic contamination or dnase has not worked properly.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PAXGENE® BLOOD DNA TUBE
Type of Device
BLOOD SPECIMEN COLLECTION DEVICE
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY (BD)
belliver way
belliver industrial estate
plymouth
UK 
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY (BD)
belliver way
belliver industrial estate
plymouth
UK  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15533534
MDR Text Key303802177
Report Number9617032-2022-00983
Device Sequence Number1
Product Code NTW
UDI-Device Identifier04053727621658
UDI-Public04053727621658
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
K082150
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/03/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date04/30/2021
Device Catalogue Number762165
Device Lot Number9233119
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/21/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-